Enanta Pharmaceuticals
ENTA
#8606
Rank
A$0.23 B
Marketcap
$10.86
Share price
-6.05%
Change (1 day)
-50.65%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - P/B ratio

P/B ratio as of March 2025 : 1.33

According to Enanta Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 2.23285.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Enanta Pharmaceuticals - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-311.1410.31%
2023-12-311.03-67.89%
2022-12-313.22-19.38%
2021-12-313.99113.3%
2020-12-311.87-26.3%
2019-12-312.54-21.32%
2018-12-313.23-8.74%
2017-12-313.5348.58%
2016-12-312.381.29%
2015-12-312.35-51.94%
2014-12-314.895.25%
2013-12-314.64
2012-12-31N/A
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
111 8,271.57%๐Ÿ‡บ๐Ÿ‡ธ USA
5.50 313.34%๐Ÿ‡บ๐Ÿ‡ธ USA
7.87 492.08%๐Ÿ‡บ๐Ÿ‡ธ USA
5.17 288.62%๐Ÿ‡บ๐Ÿ‡ธ USA
7.47 461.39%๐Ÿ‡บ๐Ÿ‡ธ USA
4.91 268.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland